Logo Image
|Videos|August 23, 2016

How Can Healthcare Professionals Help Combat Antimicrobial Resistance?

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, outlines factors that contribute to antimicrobial resistance and strategies to combat this threat.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, outlines factors that contribute to antimicrobial resistance and strategies to combat this threat.

Interview Transcript (slightly modified for readability).

“The issue of antimicrobial resistance is a global concern and a problem that needs to be looked at, at a global level. In the United States, we are the leading consumer of antibiotics on a per capita basis. In the US, 17 million kilograms of antibiotics are being used annually. A majority of those [antibiotics], 80%, [are] being used in animal husbandry and the other 20% [are] being used in humans.

Of human-use, 16% is being used in the outpatient setting. A recent study demonstrated that 30% of antibiotics being used in the outpatient setting is deemed to be 'inappropriate' [usage]. We need to control the overall use of antibiotics in agriculture as well as improve the prescribing of current antibiotics that we have available to us today.”

Related to this article

View more
How The Food Safety Surveillance Infrastructure Works in the US
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Read more
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Read more
Ceftriaxone Safety: Separating Signal From Risk
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Read more
Treatment of Latent Tuberculosis in a Trice
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Read more